Dr. Kamal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 Duke Medicine Circle
Durham, NC 27710Phone+1 919-668-6688
Summary
- Dr. Arif Kamal is an oncologist in Durham, NC and is affiliated with Duke University Hospital. He received his medical degree from University of Missouri - Kansas City School of Medicine and has been in practice 12 years. He specializes in hematologic oncology and hospice & palliative and is experienced in data collection, dyspnea, healthcare deliver, paclitaxel, and palliative care.
Education & Training
Duke University School of MedicineMHS, Clinical Research, 2012 - 2015
Duke University HospitalFellowship, Hematology and Medical Oncology, 2009 - 2012
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2005 - 2008
University of Missouri Kansas City School of MedicineClass of 2005
Certifications & Licensure
NC State Medical License 2009 - 2025
MN State Medical License 2006 - 2009
American Board of Internal Medicine Hospice and Palliative Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Palliative Care For Me (PCforMe) Start of enrollment: 2017 Jan 11
- HoPE (Hospice Preparation and Education) Start of enrollment: 2022 Jun 01
Publications & Presentations
PubMed
- Exploring the Relationship Between Smartphone GPS Patterns and Quality of Life in Patients With Advanced Cancer and Their Family Caregivers: Longitudinal Study.Kyungmi Lee, Andres Azuero, Sally Engler, Sidharth Kumar, Frank Puga
JMIR Formative Research. 2025-02-07 - Evaluating the implementation and impact of a volunteer navigation oncology support programme: study protocol for a pragmatic, real-world hybrid type 2 study.Gabrielle B Rocque, D'Ambra N Dent, Charlotte Waugh, Emily K Hill, Noah Federman
BMJ Open. 2025-01-20 - Feasibility and Acceptability of Collecting Passive Smartphone Data for Potential Use in Digital Phenotyping Among Family Caregivers and Patients With Advanced Cancer.J Nicholas Odom, Kyungmi Lee, Erin R Currie, Kristen Allen-Watts, Erin R Harrell
JCO Clinical Cancer Informatics. 2025-01-01
Journal Articles
- Incidence of Opioid-Associated Deaths in Cancer Survivors in the United States, 2006-2016Arif Kamal, MD, JAMA Oncology
Lectures
- Evaluation of a mobile application to prepare and engage cancer patients prior to a palliative care (PC) visit: Results of a randomized, controlled trial.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Value and Cost of Supportive Care2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
Authored Content
- Incidence of Opioid-Associated Deaths in Cancer Survivors in the United States, 2006-2016May 2020
Press Mentions
When ‘Cancer’ Gets in the Way of TreatmentJanuary 28th, 2025- Women More Likely to Be Diagnosed with Cancer Than Men in US, Study FindsJanuary 17th, 2025
- Older Women, Younger Adults See Uptick in Cancer CasesJanuary 16th, 2025
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
